Indegene reports Q3 results, identifies minor funds deviation
Indegene Limited (BSE:INDGN) has released its revised integrated filing for the quarter ended December 31, 2024. The company reported consolidated revenue from operations of ₹7.204 billion, a 7% increase year-over-year, and a net profit of ₹1.097 billion. The board also identified a minor, inadvertent deviation in the utilization of IPO proceeds where the group had reached 29.89% when the threshold was 25% of issue proceeds towards GCP (General Corporate Purposes) and inorganic growth. Upon recognizing the breach, Indegene promptly transferred ₹380 million back to the IPO Monitoring Account in January 2025, rectifying the error. The company listed its equity shares on the National Stock Exchange and BSE in May 2024 after a successful IPO, raising approximately ₹7.6 billion in fresh capital.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Indegene publishes news
Free account required • Unsubscribe anytime